Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $23,476,855 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 29 countries.
CONNECT Consortium - $893,678.37
$893,678.00
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
University of Massachusetts Medical School - $50,000
$50,000.00
May 2017
Advanced RNAi therapeutics for DIPG
Lucile Packard Children's Hospital Stanford - $50,000
$50,000.00
May 2017
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure
Hospital for Sick Children - $50,000
$50,000.00
September 2016
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma
Gustave Roussy Cancer Center - $93,071
$93,071.00
September 2016
Ultrasound-induced delivery of Panobinostat in preclinical models
The Hospital for Sick Children - $194,260
$194,260.00
September 2016
Exploring the interactome of H3K27M to find therapeutic targets for DIPG
Cold Spring Harbor Laboratory - $100,000
$100,000.00
September 2016
Allele-specific antisense therapy for DIPG
Children's Cancer Institute - $143,884
$143,884.00
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism
Dana-Farber Cancer Institute - $100,000
$100,000.00
December 2015
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00
December 2015
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)
Baylor College of Medicine/Texas Children's Hospital - $200,000
$200,000.00
December 2015
Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models
Children's National Health System and Children's Research Institute - $125,000
$125,000.00
December 2015
Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology
Boston Children's Hospital - $110,000
$110,000.00
December 2015
Enabling epigenetic therapies by exploring DIPG chromatin sensitivities
UCL Institute of Child Health - $200,000
$200,000.00
December 2015
T-cell based immunotherapy for DIPG.
Dana Farber Cancer Institute - $82,863
$82,863.00
December 2015
Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma